• 1. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 2. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941
• 3. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 4. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 5. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279

5-Bromo-4-ethynylpyrimidine (CAS No. 37972-19-3): A Versatile Compound in Modern Pharmaceutical Research

5-Bromo-4-ethynylpyrimidine (CAS No. 37972-19-3) is a versatile compound that has gained significant attention in the field of pharmaceutical research due to its unique chemical structure and potential applications. This compound belongs to the class of pyrimidines, which are essential building blocks in various biological processes and are widely used in the development of therapeutic agents.

The 5-bromo and 4-ethynyl substitutions on the pyrimidine ring confer distinct chemical properties that make 5-Bromo-4-ethynylpyrimidine an attractive candidate for a variety of applications. The bromine atom at the 5-position provides a handle for further functionalization, while the ethynyl group at the 4-position offers opportunities for click chemistry reactions, which are widely used in drug discovery and development.

Recent studies have highlighted the potential of 5-Bromo-4-ethynylpyrimidine in various areas of medicinal chemistry. For instance, a study published in the Journal of Medicinal Chemistry demonstrated that this compound can be used as a scaffold for the synthesis of potent inhibitors of kinases, which are key enzymes involved in many signaling pathways and are often targets for cancer therapy. The researchers found that by modifying the 5-bromo and 4-ethynyl groups, they could achieve high selectivity and potency against specific kinases.

In another study, published in Bioorganic & Medicinal Chemistry Letters, 5-Bromo-4-ethynylpyrimidine was used as a starting material to synthesize a series of antiviral agents. The researchers reported that compounds derived from this scaffold showed promising activity against several RNA viruses, including influenza and hepatitis C virus. The ethynyl group was particularly useful in enhancing the antiviral activity by facilitating the formation of stable covalent bonds with viral targets.

The versatility of 5-Bromo-4-ethynylpyrimidine extends beyond its use as a starting material for drug synthesis. It has also been employed in the development of imaging agents for diagnostic purposes. A recent study in Chemical Communications described the use of this compound to create fluorescent probes that can selectively bind to specific cellular targets. The bromine atom and ethynyl group were crucial in tuning the fluorescence properties and improving the selectivity of these probes.

In addition to its applications in drug discovery and imaging, 5-Bromo-4-ethynylpyrimidine has been explored for its potential in materials science. Researchers at a leading university have used this compound to develop novel materials with unique optical and electronic properties. The ethynyl group, in particular, has been shown to enhance the conductivity and stability of these materials, making them suitable for use in organic electronics and photovoltaic devices.

The synthesis of 5-Bromo-4-ethynylpyrimidine is well-documented in the literature. One common method involves the reaction of 4-chloropyrimidine with an appropriate brominating agent followed by a Sonogashira coupling reaction to introduce the ethynyl group. This synthetic route is highly efficient and can be scaled up for industrial production, making 5-Bromo-4-ethynylpyrimidine readily available for various research applications.

The safety profile of 5-Bromo-4-ethynylpyrimidine is another important consideration. While it is generally considered safe for laboratory use, standard precautions should be taken when handling this compound to avoid exposure to skin or inhalation. Proper storage conditions, such as keeping it away from moisture and light, are also recommended to maintain its stability.

In conclusion, 5-Bromo-4-ethynylpyrimidine (CAS No. 37972-19-3) is a highly versatile compound with a wide range of applications in pharmaceutical research, materials science, and diagnostic imaging. Its unique chemical structure, combined with its ease of synthesis and modification, makes it an invaluable tool for scientists working in these fields. As research continues to uncover new uses for this compound, it is likely to play an increasingly important role in advancing our understanding and treatment of various diseases.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)